Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kirk Calhoun Insider Profile
4 Followers
Kirk Calhoun, Director at Response Genetics, holds 1.31K shares in Ryerson Holdings (Ticker: RYI), holds 148.78K shares in NantHealth (Ticker: NHIQ), holds ― shares in PLx Pharma (Ticker: PLXPQ).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-20.40%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Kirk Calhoun holds in companies
Most Profitable Insider Trade
The most profitable trade made by Kirk Calhoun
Kirk Calhoun's Trading History
Response Genetics
Feb 06, 2012
Director
Informative Buy
15.00K
$200.37
PLx Pharma
Apr 20, 2017
―
Uninformative Buy
―
―
NantHealth
Sep 07, 2018
Director
Uninformative Buy
―
$185.97K
Ryerson Holdings
Apr 02, 2024
Director
Uninformative Buy
―
$32.54K
Cardiovascular Systems
―
―
―
$0.00
List of latest transactions for each holding click on a transaction to see Kirk Calhoun's performance on stock
You May Also Like
Kirk Calhoun insider profile FAQ
What is the percentage of profitable transactions made by Kirk Calhoun?
The percentage of profitable transactions made by Kirk Calhoun is 0%.
What is the average return per transaction made by Kirk Calhoun?
The average return per transaction made by Kirk Calhoun is -20.40%.
What stocks does Kirk Calhoun hold?
Kirk Calhoun holds: RGDXQ, PLXPQ, NHIQ, RYI, CSII stocks.
What was Kirk Calhoun’s latest transaction?
Kirk Calhoun latest transaction was an Uninformative Buy of ―.
What was Kirk Calhoun's most profitable transaction?
Kirk Calhoun’s most profitable transaction was an Informative Buy of RGDXQ stock on August 5, 2010. The return on the trade was -18.70%.
What is Kirk Calhoun's role in Response Genetics?
Kirk Calhoun's role in Response Genetics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.